Anthrax DNA vaccine - Vical/Ohio State University

Drug Profile

Anthrax DNA vaccine - Vical/Ohio State University

Latest Information Update: 30 Oct 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ohio State University; Vical
  • Class Anthrax vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Suspended Anthrax

Most Recent Events

  • 30 Oct 2006 Suspended - Phase-I for Anthrax in USA (unspecified route)
  • 16 Oct 2006 Data presented at the 44th Annual Meeting of the Infectious Diseases Society (IDSA-2006) have been added to the Bacterial Infections immunogenicity section
  • 18 Oct 2005 Data presented at the 43rd Annual Meeting of the Infectious Diseases Society (IDSA-2005) have been added to the adverse events and Bacterial Infections immunogenicity sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top